EXHIBIT 10.210 "CONFIDENTIAL TREATMENT REQUESTED BY CYGNUS, INC." U.S. MARKET RESEARCH AGREEMENT This U.S. Market Research Agreement is made effective the 22 day of February, 2001 (the "Effective Date"), between Lifescan, Inc., a Delaware corporation,...u.s. Market Research Agreement • March 27th, 2001 • Cygnus Inc /De/ • Pharmaceutical preparations • California
Contract Type FiledMarch 27th, 2001 Company Industry Jurisdiction
Contractu.s. Market Research Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 Jurisdiction<DOCUMENT> <TYPE>EX-10.210 <SEQUENCE>4 <FILENAME>a2042246zex-10_210.txt <DESCRIPTION>EX 10.210 <TEXT> <PAGE> EXHIBIT 10.210 "CONFIDENTIAL TREATMENT REQUESTED BY CYGNUS, INC." U.S. MARKET RESEARCH AGREEMENT This U.S. Market Research Agreement is made effective the 22 day of February, 2001 (the "Effective Date"), between Lifescan, Inc., a Delaware corporation, having its principal place of business at 1000 Gibraltar Drive, Milpitas, CA 95035-6312, and Cygnus, Inc., a Delaware corporation, having its principal place of business at 400 Penobscot Drive, Redwood City, California 94063. WITNESSETH WHEREAS, the parties have been engaged in discussions concerning possible business relationships relating to Cygnus' products in the field of glucose monitoring, including but not limited to, the Cygnus GlucoWatch(R) biographer; WHEREAS, Lifescan desires additional information in order to assess the market potential of the GlucoWatch(R) biographer platform prior to committing to a definitive busines